General Motors Co. (NYSE:GM) reported on Tuesday that its total March sales jumped up 6.4% to 245,950 from a year earlier same quarter.
Detroit-located General Motors’ (GM) retail sales climbed 4.4% to 178,989 in the similar phase while fleet sales climbed up 12%.
Sales of its Chevrolet brand jumped up only 0.5% to 173,859 in March while monthly sales of the Cadillac brand rallied 49.5% to 15,751.
Crossover vehicles climbed up 31% in March while trucks, which involve SUVs and pickups, moved higher 2%. Car sales declined 3% in the phase. On the whole sales were the best for March in past five years, the company reported.
General Motors Company (NYSE:GM) shares in the current session moved down -0.18% reaching at $27.75. The stock traded in a range of $27.53 – $28.30. In the last year the stock has moved within a range of $18.72 – $30.68. The current session’s volume of 7.26 million shares is lower from their average daily trading volume of 10.71 million shares.
Its archrival Ford Motor Co. (NYSE:F) announced a 5.7% increase in vehicle sales for March to 236,160 units, as compared to 223,418 vehicles a year earlier same month.
Car sales declined 0.2% to 84,611 units, while sales of utilities moved higher 13.6% to 68,548 and truck sales hiked 6% to 83,001. The top-selling car was the Fusion, higher 6.0% to 30,284 units, while sales of the F-series truck moved up 16.3% to 67,513 units.
Another rival company Ford Motor Company (NYSE:F) trading up +1.86% to $13.14. Intraday trading recorded the stock price in a range of $12.96 to $13.19. In the previous 52 weeks the stock’s price ranged between $8.82 and $14.30. The current session’s volume of 16.19 million shares was lower from their average daily trading volume of 34.02 million shares.
DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! QuoteDaddy.com delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with QuoteDaddy.com! CLICK HERE TO START YOUR FREE 30-DAY TRIAL